 | 3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate | IC50 | 15.0 [1] |
 | CID 10427006 | IC50 | 10.0 [1] |
| CID 10427006 | Ki | 9.0 [1] |
 | 1-([1,3]Oxazolo[4,5-b]pyridin-2-yl)-7-phenylheptan-1-one | IC50 | 12.0 [1] |
| 1-([1,3]Oxazolo[4,5-b]pyridin-2-yl)-7-phenylheptan-1-one | Ki | 0.28 [1] |
 | Oleyl trifluoromethyl ketone | IC50 | 187.0 [1], 600.0 [2], 4500.0 [3], 9900.0 [4] |
| Oleyl trifluoromethyl ketone | Ki | 1.2 [1], 12.0 [2], 250.0 [3] |
 | 1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)- | IC50 | 33.0 [1] |
 | N-Phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide | IC50 | 16.2 [1] |
 | 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one | IC50 | 1.0 [1] |
| 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one | Ki | 0.09 [1], 0.2 [2] |
 | 4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate | IC50 | 4000.0 [1] |
 | Benzyl N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamate | IC50 | 13.0 [1] |
 | (R)-Octan-2-yl 4-bromo-3-oxobutanoate | IC50 | 2600.0 [1], 3100.0 [2] |
| (R)-Octan-2-yl 4-bromo-3-oxobutanoate | Ki | 800.0 [1] |
 | (2R)-2-(3-Fluoro-4-phenylphenyl)-N-(3-methylpyridin-2-yl)propanamide | IC50 | 2000.0 [1] |
 | N-Phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide | IC50 | 23.0 [1], 33.0 [2], 350.0 [3], 991.0 [4] |
 | Oleoyl oxazolopyridine | IC50 | 40.0 [1] |
| Oleoyl oxazolopyridine | Ki | 2.3 [1], 13.0 [2] |
 | 1-(5-(Pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one | IC50 | 150.0 [1], 200.0 [2] |
| 1-(5-(Pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one | Ki | 3.0 [1], 10.0 [2] |
 | 6-[2-(7-Phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid | IC50 | 100.0 [1] |
| 6-[2-(7-Phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid | Ki | 10.4 [1], 20.0 [2], 26.0 [3] |
 | FAAH inhibitor 1 | IC50 | 11.0 [1], 18.0 [2], 19.0 [3], 20.0 [4], 34.0 [5] |
 | N,N-Dimethyl-5-[(4-phenylphenyl)methyl]-1-tetrazolecarboxamide | IC50 | 12.0 [1], 37.3 [2], 38.02 [3] |
 | Methoxy arachidonyl fluorophosphonate | IC50 | 0.33 [1], 1.0 [2], 3.0 [3] |
 | 1-(Oxazol-2-yl)-7-phenylheptan-1-one | IC50 | 43.0 [1], 2500.0 [2] |
| 1-(Oxazol-2-yl)-7-phenylheptan-1-one | Ki | 48.0 [1] |
 | 1-(Oxazol-2-yl)octadec-9-en-1-one | IC50 | 2000.0 [1] |
| 1-(Oxazol-2-yl)octadec-9-en-1-one | Ki | 45.0 [1], 100.0 [2] |
 | 7-Phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one | Ki | 80.0 [1] |
 | 1,1,1-Trifluorononan-2-one | IC50 | 30000.0 [1] |
| 1,1,1-Trifluorononan-2-one | Ki | 1200.0 [1] |
 | 1,1,1-Trifluorotridecan-2-one | IC50 | 10000.0 [1] |
| 1,1,1-Trifluorotridecan-2-one | Ki | 140.0 [1] |
 | 1,1,1-Trifluoro-9-phenyl-nonan-2-one | IC50 | 2000.0 [1] |
| 1,1,1-Trifluoro-9-phenyl-nonan-2-one | Ki | 25.0 [1] |
 | 3-(4-Phenylphenyl)-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]propan-1-one | Ki | 0.75 [1], 2.9 [2] |
 | 4-[[3-(4-Chlorophenoxy)phenyl]methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 6.0 [1], 9.0 [2] |
 | 4-Bromo-3-oxo-butyric acid (Z)-tetradec-5-enyl ester | IC50 | 600.0 [1], 2500.0 [2] |
| 4-Bromo-3-oxo-butyric acid (Z)-tetradec-5-enyl ester | Ki | 190.0 [1] |
 | Ethyl 1-(4-chlorophenyl)-5-[3-(cyclohexylcarbamoyloxy)phenyl]pyrazole-3-carboxylate | IC50 | 15.0 [1], 17.0 [2], 18.0 [3] |
 | Anandamide | IC50 | 3400.0 [1], 4100.0 [2] |
| Anandamide | Ki | 10000.0 [1] |
 | Aacocf3 | IC50 | 12.3 [1], 3000.0 [2] |
 | t-TUCB | IC50 | 140.0 [1], 260.0 [2], 2800.0 [3] |
 | (Z)-1-(Benzo[d]oxazol-2-yl)octadec-9-en-1-one | IC50 | 10000.0 [1] |
| (Z)-1-(Benzo[d]oxazol-2-yl)octadec-9-en-1-one | Ki | 73.0 [1] |
 | 7-Phenyl-1-[5-(Pyridin-2-Yl)-1,3,4-Oxadiazol-2-Yl]heptan-1-One | IC50 | 1.0 [1] |
| 7-Phenyl-1-[5-(Pyridin-2-Yl)-1,3,4-Oxadiazol-2-Yl]heptan-1-One | Ki | 0.29 [1], 1.2 [2] |
 | 2-(7-Phenylheptanoyl)oxazole-5-carbonitrile | IC50 | 6.5 [1] |
| 2-(7-Phenylheptanoyl)oxazole-5-carbonitrile | Ki | 0.4 [1], 1.0 [2] |
 | 2-Nonadecanone, 1,1,1-trifluoro- | IC50 | 6400.0 [1] |
| 2-Nonadecanone, 1,1,1-trifluoro- | Ki | 240.0 [1] |
 | 1,1,1-Trifluoro-8-phenyl-octan-2-one | IC50 | 5000.0 [1] |
| 1,1,1-Trifluoro-8-phenyl-octan-2-one | Ki | 100.0 [1] |
 | 1,1,1-Trifluoro-undecan-2-one | IC50 | 10000.0 [1] |
| 1,1,1-Trifluoro-undecan-2-one | Ki | 130.0 [1] |
 | 1-(Oxazolo[4,5-b]pyridin-2-yl)-8-phenyloctan-1-one | IC50 | 0.3 [1] |
| 1-(Oxazolo[4,5-b]pyridin-2-yl)-8-phenyloctan-1-one | Ki | 0.39 [1] |
 | 1-(Oxazolo[4,5-b]pyridin-2-yl)-9-phenylnonan-1-one | IC50 | 0.1 [1] |
| 1-(Oxazolo[4,5-b]pyridin-2-yl)-9-phenylnonan-1-one | Ki | 0.52 [1] |
 | 2-(7-Phenylheptanoyl)oxazole-5-carboxylic acid | IC50 | 970.0 [1] |
| 2-(7-Phenylheptanoyl)oxazole-5-carboxylic acid | Ki | 30.0 [1], 32.0 [2] |
 | 1-Piperazinecarboxamide, 4-((3-(4-chlorophenoxy)phenyl)methyl)-N-3-pyridinyl- | IC50 | 1.4 [1] |
 | Carbamic acid,N-[6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]-,2-fluorophenyl ester | IC50 | 1.7 [1], 2.0 [2] |
 | 3-(4-(Phenoxymethyl)phenyl)-1-(5-(pyridin-2-yl)oxazol-2-yl)propan-1-one | Ki | 1.0 [1], 5.0 [2] |
 | 2-(3-(Biphenyl-4-yl)propanoyl)oxazole-5-carbonitrile | Ki | 0.2 [1], 0.26 [2] |
 | [3-[(S)-(4-Chlorophenyl)-(2-chloropyridin-3-yl)methoxy]azetidin-1-yl]-piperidin-1-ylmethanone | IC50 | 78.0 [1], 140.0 [2], 973.0 [3] |
 | [(1R)-1-[(3S)-2-Oxo-1-pent-4-enoylazetidin-3-yl]ethyl] 4-phenylbutanoate | IC50 | 5.32 [1], 5.37 [2] |
 | 4-[(3-Phenoxyphenyl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 74.0 [1], 80.0 [2], 3020.0 [3] |
 | 3'-Carbamoyl-biphenyl-3-yl-hexylphenylcarbamate | IC50 | 14.0 [1], 36.0 [2] |
 | [3-[(R)-(4-Chlorophenyl)-(2-chloropyridin-3-yl)methoxy]azetidin-1-yl]-piperidin-1-ylmethanone | IC50 | 10000.0 [1], 500000.0 [2] |
 | 4-[(5-Bromo-2-hydroxy-3-methoxyphenyl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 120.0 [1], 130.0 [2], 210.0 [3] |
 | N-(3-Methylpyridin-2-yl)-2-[4-[[2-(trifluoromethyl)pyridin-4-yl]amino]phenyl]propanamide | IC50 | 1900.0 [1], 2200.0 [2], 2500.0 [3] |
 | 4-Bromo-3-oxo-butyric acid heptyl ester | IC50 | 1500.0 [1], 2100.0 [2] |
| 4-Bromo-3-oxo-butyric acid heptyl ester | Ki | 550.0 [1] |
 | (Z)-1-Bromo-nonadec-10-en-2-one | IC50 | 1000.0 [1], 5300.0 [2] |
| (Z)-1-Bromo-nonadec-10-en-2-one | Ki | 390.0 [1] |
 | 4-Chloro-3-oxo-butyric acid (R)-1-methyl-heptyl ester | IC50 | 700.0 [1], 2900.0 [2] |
| 4-Chloro-3-oxo-butyric acid (R)-1-methyl-heptyl ester | Ki | 1100.0 [1] |
 | 4-[(1-Hydroxynaphthalen-2-yl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 16.0 [1], 21.0 [2], 50.0 [3] |
 | 4-[(5-Bromo-2-hydroxyphenyl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 290.0 [1], 330.0 [2], 410.0 [3] |
 | 4-[(2-Hydroxyphenyl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 1300.0 [1], 3000.0 [2], 10000.0 [3] |
 | 4-[(2,2-Difluoro-1,3-benzodioxol-5-yl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 87.0 [1], 100.0 [2], 290.0 [3] |
 | N-(4-Fluorophenyl)-4-(quinolin-3-ylmethyl)piperazine-1-carboxamide | IC50 | 130.0 [1], 220.0 [2], 6500.0 [3] |
 | N-Phenyl-4-[(4-propan-2-ylphenyl)methyl]piperazine-1-carboxamide | IC50 | 220.0 [1], 380.0 [2], 10000.0 [3] |
 | 4-[(3,4-Dibromophenyl)methyl]-N-phenylpiperazine-1-carboxamide | IC50 | 19.0 [1], 38.0 [2], 270.0 [3] |
 | 4-(Naphthalen-2-ylmethyl)-N-phenylpiperazine-1-carboxamide | IC50 | 17.0 [1], 23.0 [2], 265.0 [3] |
 | Carbaryl | IC50 | 30000.0 [1] |
 | Benzil | IC50 | 40000.0 [1] |
 | Amperozide | IC50 | 455.0 [1], 1340.0 [2] |
 | Phenmedipham | IC50 | 152.0 [1], 377.0 [2] |
 | Cyclohexyl biphenyl-3-ylcarbamate | IC50 | 5650.0 [1], 5754.4 [2] |
 | Arachidonoyl Serotonin | IC50 | 12000.0 [1], 16000.0 [2] |
 | 3-Octylthio-1,1,1-trifluoro-2-propanone | IC50 | 230.0 [1], 300.0 [2] |
 | Biphenyl-N-cyclopentyl-carbamate | IC50 | 63.0 [1] |
 | 4-(1,3-Benzodioxol-5-ylmethyl)-N-phenylpiperazine-1-carboxamide | IC50 | 1200.0 [1], 8000.0 [2] |
 | CID 76313567 | IC50 | 4800.0 [1] |
 | Farinosone A | IC50 | 1200.0 [1], 10000.0 [2] |
Calculator
